Conjugated hepcidin mimetics

Hepcidin analogue peptides with enhanced properties address the challenges of treating Polycythemia vera by regulating iron homeostasis and reducing erythropoiesis, offering a more effective and less invasive treatment option than phlebotomy.

AU2026205090A1Pending Publication Date: 2026-07-16PROTAGONIST THERAPEUTICS INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
PROTAGONIST THERAPEUTICS INC
Filing Date
2026-06-29
Publication Date
2026-07-16

Smart Images

  • Figure 00000115_0000
    Figure 00000115_0000
  • Figure 00000115_0001
    Figure 00000115_0001
  • Figure 00000116_0000
    Figure 00000116_0000
Patent Text Reader

Abstract

20 26 20 50 90 29 J un 2 02 6 A B S T R A C T 2 0 2 6 2 0 5 0 9 0 2 9 J u n 2 0 2 6
Need to check novelty before this filing date? Find Prior Art